Sustainable Innovation as The Greatest Good

In order to achieve our mission, our R&D department and the not-for-profit research center Scientia Terrae collaborate daily to test our products and develop new innovations. Thanks to their intensive analyses, we only bring the most efficient solutions to market. This means that the environmental impact is as low as possible, which is exactly what we want to achieve: products that benefit nature both in the short and the long term.

Our MINIGRAN® technology, used for the production of our organic and organo-mineral fertilizers, is a good example of product innovation. We developed mini-granules that contain all the nutrients derived from organic raw materials (nitrogen, phosphorus, potassium, magnesium and trace elements).

These nutrients are gradually released by microbial activity as soon as the fertilizer granules reach the soil. Microbial activity is closely linked to plant growth, which means that the nutrients in our products are only released when the plant really needs them.

Our soil improvers and potting soils are continuously optimized with appropriate organic fertilizers, lime and other valuable components depending on the application or plant, for optimal soil fertility. As a result of our own research and tests, DCM has also launched two biostimulants that increase plant vitality and root system activity.

In 2020 we will launch a brand new line of liquid fertilizers. These products consist of 98% natural ingredients and are supplemented with 2% micro-organisms and trace elements, so that they can also be used in organic gardening.

Did you know?

Did you know that we collaborate, through our plant clinic, with more than 20 research departments of universities and trial stations in Belgium, the Netherlands and abroad? Practical trials on a grower’s premises and on sports fields in the 45 countries in which we are active, are also very important to continuously improve our products. Equally important is the internal and cross-border sharing of knowledge that our DCM advisors acquire with those trials.